Citi lifts Novo Nordisk target on strong GLP-1 pill launch
Citi lifts Novo Nordisk target on strong GLP-1 pill launch
Citi lifts Novo Nordisk target on strong GLP-1 pill launch
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.